FAQ

Show All
What is Accuray’s ticker symbol?
ARAY
On what exchange is Accuray traded?
The company is traded on the Nasdaq Global Select Market.
When was the company founded and where is it incorporated?
Accuray was incorporated in California in 1990 and commenced commercial operations in 1992. Accuray re-incorporated in Delaware in 2007.
Where is Accuray located?

Accuray Corporate Headquarters is located at:
1310 Chesapeake Terrace
Sunnyvale, CA 94089

Accuray International Headquarters is located at:
Rte de la Longeraie 9
1110 Morges
Switzerland

Outside of the United States, Accuray currently has regional offices in Morges, Switzerland, Hong Kong, China, Shanghai, China and Tokyo, Japan.

What does Accuray do?

Accuray Incorporated is a radiation therapy company that develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments for even the most complex cases, while making commonly treatable cases even more straightforward, to meet the full spectrum of patient needs. The company’s treatment delivery, planning, and data management solutions provide better accuracy, flexibility, and control; fewer treatments with shorter treatment times; and the technology to expand beyond cancer, making it easier for clinical teams around the world to provide treatments that help patients get back to living their lives, faster.

Accuray solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments.

  • Unique artificial intelligence driven radiation therapy systems automatically adapt treatment delivery for targets that move, synchronizing the radiation beam with the targets motion in real-time throughout treatment delivery.
  • Automated tools help to identify between fraction changes for which re-planning is clinically beneficial and facilitate adaptation of the radiation dose precisely to the patient’s tumor.
  • Distinctive software accelerates and automates the re-planning process to make re-treatment of a previously irradiated area more efficient for practices and more effective for patients.

Our innovative technologies, the CyberKnife® and TomoTherapy® platforms, including the Radixact® System, our next generation TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). The CyberKnife and TomoTherapy platforms have complementary clinical applications with the same goal: to empower customers to deliver the most precise and accurate treatments while still minimizing dose to healthy tissue, helping to reduce the risk of side effects that may impact patients’ quality of life. Each of these systems serves patient populations treated by the same medical specialty, radiation oncology, with advanced capabilities. The CyberKnife platform is also used by neuro-radiosurgeons to treat patients with tumors in the brain and neurologic disorders. In addition to these products, we also provide services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other professional services.

Our Vision and Mission:
We work passionately to expand the curative power of radiation therapy to improve as many lives as possible. We pursue this by thinking, acting, and executing beyond expectations every day to deliver better, safer radiation therapy solutions and help patients get back to living their lives, faster.

How are Accuray’s products sold?
Accuray currently markets its systems through a combination of direct sales personnel, distributors and sales agents.
Where are the Accuray radiation therapy systems installed?
The CyberKnife® and TomoTherapy® platforms, including the Radixact System, our next generation TomoTherapy platform, are installed in leading healthcare centers in approximately 50 countries globally.
Are Accuray’s products cleared by the U.S. Food and Drug Administration (FDA) and other regulatory agencies?
The CyberKnife® and TomoTherapy® platforms, including the Radixact® System, our next generation TomoTherapy platform, and various associated software technologies are cleared for use in numerous countries throughout the world, having received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW); Accuray products have also received CE Mark certification.
How many employees does Accuray have?
Accuray has approximately 1,000 employees worldwide.
When does Accuray’s fiscal year end?
Accuray’s fiscal year ends on June 30.
When is Accuray Incorporated’s next report of quarterly results?
Please see our Calendar of Events.
Who is Accuray’s transfer agent?

Computershare Inc.
(800) 362-7920
(800) 952-9245 (Hearing Impaired)
(201) 680-6578 (Foreign Shareholders)
www.computershare.com/investor

Mailing address:
Accuray Incorporated
c/o Computershare Inc.
250 Royall Street
Canton MA 02021

How do I get more information?
To contact the investor relations department directly, please refer to the Investor Contact section of this site, and to email us, click here.